Masimo (NASDAQ:MASI) Updates Q4 2024 Earnings Guidance

Masimo (NASDAQ:MASI) issued an update on its fourth quarter 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.350-1.500 for the period, compared to the consensus earnings per share estimate of 1.410. The company issued revenue guidance of $581.0 million-$611.0 million, compared to the consensus revenue estimate of $607.4 million. Masimo also updated its FY24 guidance to $3.95-$4.10 EPS.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Raymond James upgraded Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price objective on the stock in a report on Wednesday. Piper Sandler lifted their price target on Masimo from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Wednesday. BTIG Research boosted their price target on Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Wells Fargo & Company raised their price objective on Masimo from $160.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Wednesday. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $152.57.

Masimo Trading Up 1.1 %

Masimo stock traded up $1.79 during trading on Friday, reaching $163.14. 79,263 shares of the company were exchanged, compared to its average volume of 680,965. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. The stock’s 50 day simple moving average is $132.63 and its two-hundred day simple moving average is $125.88. The company has a market capitalization of $8.68 billion, a P/E ratio of 112.44 and a beta of 0.97. Masimo has a 52-week low of $81.82 and a 52-week high of $173.90.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The firm had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $502.87 million. During the same quarter in the previous year, the company posted $0.63 EPS. The company’s revenue was up 5.4% compared to the same quarter last year. On average, equities research analysts expect that Masimo will post 3.88 earnings per share for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.